Results 41 to 50 of about 100,760 (212)

Solitary plasmacytoma. I: Extramedullary soft tissue plasmacytoma [PDF]

open access: yesCancer, 1979
The details of 16 patients with extramedullary plasmacytoma are presented. All but one presented with localized disease, and all were treated successfully by radiotherapy. Only one patient developed local recurrence and only one has developed disseminated disease.
R K, Woodruff, J M, Whittle, J S, Malpas
openaire   +2 more sources

Solitary Plasmacytoma of the Mesentery: A Systematic Clinician’s Diagnosis

open access: yesCase Reports in Oncological Medicine, 2017
Introduction. Plasmacytoma is an uncommon plasma cell neoplasm and its localized form is solitary plasmacytoma of the bone and solitary extramedullary plasmacytoma.
Georgia Mitropoulou   +5 more
doaj   +1 more source

A Refractory Leg Skin Ulcer Associated With Multiple Myeloma Successfully Treated With Plasma Exchange, Lenalidomide, and Dexamethasone

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Multiple myeloma (MM) is a malignant plasma cell disorder that primarily presents with CRAB symptoms (calcium elevation, renal failure, anemia, and bone abnormalities). In rare cases, MM manifests with systemic complications like skin ulcers, which present management challenges. Here, we report a 78‐year‐old Japanese man with MM and refractory
Naoko Hattori   +5 more
wiley   +1 more source

Concomitant plasmacytoma and B cell lymphoma with discordant light chain expression but clonal identity [PDF]

open access: yes, 2012
Letter to the editorpublished_or_final_versionSpringer Open Choice, 25 May ...
Au, WY, Choi, WWL, Lau, WH, Wong, KY
core   +1 more source

Solitary bone plasmacytoma and extramedullary plasmacytoma

open access: yesCurrent Treatment Options in Oncology, 2002
Solitary bone and extramedullary plasmacytomas are rare plasma cell proliferative disorders. Their diagnosis is based on histologic confirmation of monoclonal plasma cell infiltration of a single disease site and on the exclusion of systemic myeloma. For both entities, the treatment of choice is localized radiotherapy. With modern radiotherapy and with
Dimopoulos, Meletios A, Hamilos, George
openaire   +4 more sources

A Case Report of a Special Type of Multiple Myeloma: Kappa Light Chain‐Only

open access: yesOrgan Medicine, EarlyView.
This case illustrates the clinical course of a patient diagnosed with kappa light chain‐only multiple myeloma, a rare subtype of multiple myeloma. Of note, light chain multiple myeloma is characterized by rapid disease progression and severe target organ damage.
Yanhua Dai   +8 more
wiley   +1 more source

Plasmablastic plasmacytoma of the rectum and anal canal in a patient with ulcerative colitis

open access: yesGastroenterology Review, 2021
Plasma cell neoplasms (PCN) represents a group of tumours originating from abnormal plasma cells, which are further classified into multiple myeloma (MM), medullary plasmacytoma (MP), and extramedullary plasmacytoma (EMP) [1, 2].
Katarina Jankovic   +3 more
doaj   +1 more source

An unusual case of multiple myeloma [PDF]

open access: yes, 2013
The case concerns the unusual presentation of a non-secretory multiple myeloma with diarrhoea secondary to large bowel infiltration. In December 2009, a 74-year-old lady presented to hospital and complained of a two year history of intermittent ...
Delicata, Julian, Farrugia, Daniel
core  

Posttransplant lymphoproliferative disorders in adult and pediatric renal transplant patients receiving tacrolimus-based immunosuppression [PDF]

open access: yes, 1999
Between March 27, 1989 and December 31, 1997, 1316 kidney transplantations alone were performed under tacrolimus-based immunosuppression at our center.
Ellis, D   +15 more
core   +1 more source

Update on Non‐Biological and RNA‐Based Therapeutics in Chronic Inflammatory Diseases: Precision Medicine Through Small Molecules: An EAACI Position Paper

open access: yesAllergy, EarlyView.
ABSTRACT In the last decades, critical advancements in research technology and knowledge on disease mechanisms steered therapeutic approaches for chronic inflammatory diseases towards unprecedented target specificity. For allergic and chronic lung diseases, biologic drugs pioneered this goal, acquiring on the way—through the clinical use of monoclonal ...
F. Roth‐Walter   +20 more
wiley   +1 more source

Home - About - Disclaimer - Privacy